Neurobiology and Clinical Neuroscience
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of the treatment of neurobiology and neurologic diseases. Topics include, but are not limited to neurogenesis, neuroplasticity, neuropharmacology, and neurotherapeutics, in vitro and in vivo responses to neurological diseases, identification of therapeutic targets, evaluation of diagnostic markers, and assessment of therapies for neurological disorders.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Molecular Research of Neurological and Psychiatric Disorders (Deadline: 30 April 2025)
- Biomarkers for Neurodegenerative Disorders: From Bench to Bedside (Deadline: 30 April 2025)
- Neurotrauma: Mechanisms, Pathways, and Emerging Therapeutic Interventions (Deadline: 30 April 2025)
- Oxidative Stress and Proteinopathy in Alzheimer's Disease (Deadline: 30 April 2025)
- Advances in Depression Research: Neurobiology, Models, Biomarkers and Therapies (Deadline: 30 April 2025)
- Advances in Neurological Diseases: Pathogenesis, Diagnosis and Therapeutic Strategies (Deadline: 31 May 2025)
- Neuroinflammation and Neuroprotection (Deadline: 31 May 2025)
- Advanced Research in Neuroprotection (Deadline: 31 May 2025)
- The Interplay Between miRNA and Mitochondrial Dysfunction in Neurodegenerative Diseases (Deadline: 31 May 2025)
- Recent Advances in Understanding of the Role of Synuclein Family Members in Health and Disease: Third Edition (Deadline: 31 May 2025)
- Neuromuscular Diseases: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 May 2025)
- State-of-the-Art Neurobiology and Clinical Neuroscience in the United States (Deadline: 31 May 2025)
- Brain Injury: New Insights into Mechanisms and Future Promising Treatments—Second Edition (Deadline: 31 May 2025)
- Biomarkers in Neurological Disorders (Deadline: 31 May 2025)
- Clinical, Radiological, and Molecular Insights into Craniopharyngioma (Deadline: 31 May 2025)
- Neurovascular Dysfunction: Mechanisms and Therapeutic Strategies (Deadline: 31 May 2025)
- New Advances in Epilepsy Research (Deadline: 31 May 2025)
- Parkinson’s Disease: Where Are We and Where Are We Going To (Deadline: 31 May 2025)
- From Pathophysiology to Novel Therapeutic Approaches in Alzheimer’s Disease (Deadline: 31 May 2025)
- Recent Therapeutic Advances in Parkinson’s Disease (Deadline: 31 May 2025)
- Molecular Mechanisms and Therapy of Gliomas (Deadline: 31 May 2025)
- Spinal Muscular Atrophy: Pathogenesis, Diagnosis, Therapeutics and Future Directions (Deadline: 1 June 2025)
- Neurodegenerative Diseases: Recent Advances and Future Perspectives, 2nd Edition (Deadline: 25 June 2025)
- Current Aspects on the Therapeutics of Aging, Cellular Senescence and Neurodegenerative Diseases (Deadline: 30 June 2025)
- Encephalitis and Viral Infection: Mechanisms and Therapies (Deadline: 30 June 2025)
- Microglia in Neurodegenerative Diseases: Key Mediators of Apoptosis and Inflammatory Pathways (Deadline: 30 June 2025)
- Mechanisms and Therapeutic Strategies of Brain and Spinal Cord Injury (Deadline: 30 June 2025)
- Neural Nexus: Interdisciplinary Perspectives on Neurological Disorders (Deadline: 30 June 2025)
- Biomarkers, Surrogate Markers and New Therapeutic Insights into Multiple Sclerosis (Deadline: 30 June 2025)
- Nanomedicine Applications in the Diagnosis and Treatment of Neurodegenerative Diseases (Deadline: 30 June 2025)
- Molecular Mechanisms and Novel Therapies for Brain Injury: 2nd Edition (Deadline: 30 June 2025)
- Neural Organoids: Advancing Our Understanding of the Central and Peripheral Nervous Systems (Deadline: 30 June 2025)
- Neurotransmitters in Health and Diseases (Deadline: 30 June 2025)
- Molecular Research of Neurodegenerative and Psychiatric Diseases, 2nd Edition (Deadline: 30 June 2025)
- Imaging and Neurochemical Biomarkers in Parkinsonian Disorders (Deadline: 30 June 2025)
- Emerging Research in Neurorehabilitation, 2nd Edition (Deadline: 30 June 2025)
- Cellular and Molecular Biology of Neurodegenerative Disorders (Deadline: 31 July 2025)
- Demyelinating Diseases: Pathophysiology and Emerging Therapeutic Targets (Deadline: 31 July 2025)
- Autonomic Dysfunction in Neurological Disorders: Novel Mechanisms and Targets (Deadline: 31 July 2025)
- Advanced in Schizophrenia Research and Treatment (Deadline: 31 July 2025)
- State-of-the-Art Pain Medicine (Deadline: 31 July 2025)
- Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical, and Translational Neuropsychiatry—Second Edition (Deadline: 31 July 2025)
- Glioblastoma: From Pathology to Novel Therapeutic Approaches (Deadline: 31 July 2025)
- Animal Models of Neurological Disorders: Where Are We Now? (3rd Edition) (Deadline: 31 July 2025)
- Recent Advances in Craniofacial Pain and Headaches—Second Edition (Deadline: 31 July 2025)
- Amyloid-β Dynamics and Neurodegeneration: Mechanistic Insights and Therapeutic Strategies (Deadline: 31 July 2025)
- Multiple Sclerosis: Diagnosis and Treatment—3rd Edition (Deadline: 31 August 2025)
- Neurodegenerative Diseases: From Mechanisms to Therapeutic Approaches, 2nd Edition (Deadline: 31 August 2025)
- Brain Imaging and Cognitive Deficits in Psychiatric Disorders, 2nd Edition (Deadline: 31 August 2025)
- Mechanisms and Novel Therapeutic Approaches for Neurodegenerative Diseases (2nd Edition) (Deadline: 31 August 2025)
- Mitochondrial Dysfunction and Oxidative Stress (Deadline: 31 August 2025)
- Advancements in Brain Diagnosis and Treatment: From Insights to Innovations (Deadline: 31 August 2025)
- Biomedical and Biochemical Basis of Neurodegenerative Diseases (Deadline: 31 August 2025)
- Neuroendocrine Neoplasia and Endocrine Tumors: Pathogenic Features, Prognostic Markers and New Therapeutic Approaches (Deadline: 31 August 2025)
- Advancements in Neuroscience: A Special Issue in Honour of Ramón Y Cajal (Deadline: 30 September 2025)
- Neuromuscular Diseases: Biochemical, Genetic, and Electrophysiological Studies (Deadline: 30 September 2025)
- Medical Imaging in Brain Tumor: Charting the Future (Deadline: 30 September 2025)
- Molecular Characteristics of Cerebral Ischemia and Their Therapeutic Applications (Deadline: 30 September 2025)
- Neurodevelopmental Disorders: From Pathophysiology to Novel Therapeutic Approaches—2nd Edition (Deadline: 30 September 2025)
- Advanced Molecular Mechanisms and Treatment of Neurological Diseases (Deadline: 30 September 2025)
- Epilepsy: Pathomechanism, Diagnostics, and Novel Treatment Options (Deadline: 30 September 2025)
- Neuroscience Through Electrophysiology: Current Trends and Future Directions (Deadline: 30 September 2025)
- Advances in Stroke Neuroprotection and Repair (Deadline: 30 September 2025)
- Dualistic Equilibrium in Neurotransmission and Beyond: Unraveling the Pathophysiology and Unlocking Novel Therapeutic Targets in Neuropsychiatric Disorders—2nd Edition (Deadline: 31 October 2025)
- New Molecular Insights into the Pathogenesis and Drug Development of Neurodegenerative Diseases: 2nd Edition (Deadline: 31 October 2025)
- Diagnostic Biomarkers and Novel Therapeutics Targets for Fragile X Syndrome, Autism Spectrum Disorders and Genetic Neurodevelopmental Diseases: Advances and Challenges, 2nd Edition (Deadline: 31 October 2025)
- PET and SPECT Imaging for the Diagnosis of Neurodegenerative Diseases (Deadline: 31 October 2025)
- The Intricacies of Developmental and Epileptic Encephalopathies: A Journey Towards Innovative Therapies (Deadline: 31 October 2025)
- Protein Misfolding and Functional Impairment in Neurodegenerative Diseases (Deadline: 31 October 2025)
- Cell Signaling and Molecular Regulation in Neurodegenerative Disease (Deadline: 31 October 2025)
- Neurodevelopmental Disorders: From Mechanisms to Therapeutic Approaches (Deadline: 31 October 2025)
- Emerging Therapeutic Strategies for Epilepsy: Bridging Research and Clinical Practice (Deadline: 31 October 2025)
- Molecular and Histopathological Background of Diabetic Neuropathy (Deadline: 30 November 2025)
- Advances in Neurophysiology and the Treatment of Parkinson’s Disease (Deadline: 30 November 2025)
- Neurodegeneration No More: Cutting-Edge Technologies and Therapies in the Evolution of Neurodegenerative Disease Management—2nd Edition (Deadline: 30 November 2025)
- Progress in Neurodevelopmental Disorders Research (Deadline: 30 November 2025)
- Traumatic CNS Injury: From Bench to Bedside (2nd Edition) (Deadline: 31 December 2025)
- Glioblastoma: Pathogenetic, Diagnostic and Therapeutic Perspectives (Deadline: 28 February 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Feature Papers in Neuromodulation and Brain Stimulation
- Nervous System Inflammation
- Neurodegeneration No More: Cutting-Edge Technologies and Therapies in the Evolution of Neurodegenerative Disease Management
- Neurodevelopmental Disorders: From Pathophysiology to Treatment
- Neurogenic Neuroinflammation in Fibromyalgia
- Neurotoxicity: Mechanisms and Potential Therapeutic Strategies (Closed)
- Preclinical Breakthroughs to Clinical Frontiers: Translating Molecular Psychiatry
